ArticleESC heart failure2022
Effects of the COVID-19 pandemic on heart failure hospitalizations in Japan: interrupted time series analysis.
Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 38 citations in OpenAlex.
- Changes in Referral Rates After the Mandate of Charging Additional Fees for Non-referral First Visits: A Controlled Interrupted Time-series Analysis.Journal of epidemiology · 2026Article
- Age-specific impact of COVID-19 on birth rates in Japan: An interrupted time-series analysis using national vital statistics.PloS one · 2026Article
- Self-care and fatigue in individuals hospitalized with decompensated heart failure during the covid-19 pandemic: a cross-sectional study.Revista latino-americana de enfermagem · 2026Observational
- Impact of the COVID-19 pandemic on admission trends, diagnosis patterns, and demographics of ischemic heart disease patients: a retrospective study.Journal of cardiothoracic surgery · 2025Article
- Impact of the COVID-19 pandemic on continuity of medical treatment for patients with chronic diseases in Japan: a retrospective cohort analysis.BMC health services research · 2025Article
- Temporal trends and disparities in mortality from hypertensive heart disease with heart failure: A nationwide analysis (1999-2020).International journal of cardiology. Cardiovascular risk and prevention · 2025Article
- Article
- Demographic trends and disparities in mortality related to coexisting heart failure and diabetes mellitus among older adults in the United States between 1999 and 2020: A retrospective population-based cohort study from the CDC WONDER database.International journal of cardiology. Cardiovascular risk and prevention · 2024Article
- Myocarditis Associated with COVID-19 Vaccination.Vaccines · 2024Review
- The trends of antihypertensive drug prescription based on the Japanese national data throughout the COVID-19 pandemic period.Hypertension research : official journal of the Japanese Society of Hypertension · 2024Article
- Time series analysis of COVID-19's impact on physician and dentist visits in Iran.Scientific reports · 2024Article
- Effects of the COVID-19 pandemic on the rates of adverse birth outcomes and fetal mortality in Japan: an analysis of national data from 2010 to 2022.BMC public health · 2024Article
- Impact of COVID-19 on healthcare utilization among chronic disease patients in South Korea.Preventive medicine reports · 2024Article
- Risk factors of readmission and the impact of outpatient management in heart failure patients: A national study in Japan.ESC heart failure · 2023Article
- Prescription of renin-angiotensin system inhibitors in Japan during the COVID-19 pandemic: interrupted time series study.Hypertension research : official journal of the Japanese Society of Hypertension · 2023Article
- Cardiovascular Hospitalizations and Hospitalization Costs in Japan During the COVID-19 Pandemic.Circulation reports · 2023Article
- Health Care Utilization and Death in Patients With Heart Failure During the COVID-19 Pandemic.Mayo Clinic proceedings. Innovations, quality & outcomes · 2023Article
- A Review of Heart Failure in Patients with COVID-19.Heart failure clinics · 2023Review
- Hospitalizations and mortality of patients with heart failure in the COVID-19 era in Peru.Journal of Taibah University Medical Sciences · 2023Article
- Postoperative mortality analysis on nationwide data from diagnosis procedure combination database in Japan.PloS one · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
aimsThe Coronavirus Disease 2019 (COVID-19) pandemic has had unprecedented effects on health care utilization for acute cardiovascular diseases. Although hospitalizations for acute coronary syndrome decreased during the COVID-19 pandemic, there is a paucity of data on the trends and management of heart failure (HF) cases. Furthermore, concerns have been raised that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) may increase susceptibility to COVID-19. This study aimed to elucidate changes in HF hospitalizations from the COVID-19 state of emergency in Japan and investigated changes in the prescription of ACEIs and ARBs, and in-hospital mortality. METHODS AND
resultsWe performed an interrupted time series analysis of HF hospitalizations in Japan to verify the impacts of the COVID-19 state of emergency. Changes in the weekly volume of HF hospitalizations were taken as the primary outcome measure. Between 1 April 2018 and 4 July 2020, 109 429 HF cases required admission. After the state of emergency, an immediate decrease was observed in HF cases per week [-3.6%; 95% confidence interval (CI): -0.3% to -6.7%, P = 0.03]. There was no significant change in the prescription of ACEIs or ARBs after the state of emergency (4.2%; 95% CI: -0.3% to 8.9%, P = 0.07). The COVID-19 pandemic had no effect on in-hospital mortality among HF patients (5.3%; 95% CI: -4.9% to 16.6%, P = 0.32).
conclusionsWe demonstrated a decline in HF hospitalizations during the COVID-19 pandemic in Japan, with no clear evidence of a negative effect on the prescription of ACEIs and ARBs or in-hospital mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.